Anhydrous dry-film Na3SbS4 thioantimonate electrolyte for sodium solid-state batteries

The solid-state battery industry is bifurcating along two electrolyte chemistries for sodium systems: thiophosphate (Na3PS4 and its doped variants) and thioantimonate (Na3SbS4 and selenide derivatives). Nearly all near-term investment and academic attention has followed the thiophosphate branch, leaving thioantimonate largely in the hands of a small number of incumbents whose claims, in many cases, cover only bulk composition or hydrate-derived synthesis routes. This asset occupies the negative space: a dry-film, anhydrous processing route combined with a sodium-metal interfacial stabilization architecture, protected not at the composition level but at the process and architecture level — exactly the territory that composition-focused incumbents leave open. The strategic purpose is candid: this is a freedom-to-operate backstop within the solid-state battery electrolytes and interfaces portfolio. If a given jurisdiction's patent landscape blocks access to preferred divalent-doped Na3PS4 compositions, a licensor or manufacturing partner can pivot to this asset and continue operating under dry-film process protection without infringing the composition-of-matter rights that encumber the underlying Na3SbS4 material. That is a narrower position than a composition patent, but it is a real one — and in the fast-moving sodium cell space, process and architecture claims frequently outlast composition claims as the prior art base expands. The timing logic flows from sodium-ion cell manufacturing buildout. As sodium-ion cells advance from pilot to GWh-scale production — particularly in China, India, and emerging low-cost grid storage markets — manufacturers seeking sulfide solid-state electrolytes will face licensing bottlenecks on bulk compositions. A ready-to-license dry-film process route, with demonstrated interfacial architecture and freedom-to-operate opinion in hand, becomes a tangible asset for a manufacturer navigating that landscape. The window is not a sprint; it scales with sodium solid-state cell adoption, which is measured in years to a decade, giving the portfolio time to develop the validation data this asset still requires.

The engines did not fully agree here — the asset carries that uncertainty openly rather than overstating confidence.

Sodium thioantimonate, Na3SbS4, belongs to the same tetragonal superionic family as Na3PS4 and shares the characteristic that its sulfur sublattice undergoes significant thermal motion at operating temperatures — a feature that is mechanistically responsible for fast sodium-ion conduction rather than a sign of structural collapse. The computational stability assessment from four independent machine-learning interatomic potentials (MACE, CHGNet, MatterSim, and ORB) each report soft phonon modes for this structure. Critically, this is understood to be a mobile-sublattice signature rather than a thermodynamic instability: the soft modes reflect the shallow energy landscape that enables superionic diffusion, not an imaginary-frequency indication of a structure that will decompose. One DFT source corroborates this interpretation. The distinction matters because "soft" in a known mobile-sublattice conductor has a different implication than "soft" in a candidate where such behavior is unexpected. The selenium-substituted series Na3SbS4-xSex (with x ranging continuously up to 2) expands the composition space by partially replacing sulfur with selenium. Selenium substitution is well-established in the broader thio- and selenoantimonate literature to tune lattice polarizability, ionic conductivity, and electrochemical window. The computed electronic bandgap for the base Na3SbS4 composition sits at approximately 1.9 eV — wide enough to support a reasonable electrochemical stability window for sodium metal operation, though experimental validation of the actual electrochemical window on anhydrous dry-film specimens has not yet been completed. This is an explicit open gate. The process innovation that anchors the claims centers on anhydrous, hydrate-free synthesis. Na3SbS4 is acutely sensitive to atmospheric moisture; conventional synthesis from hydrate precursors introduces residual water that degrades ionic conductivity and creates parasitic reactions at sodium-metal interfaces. The dry-film approach uses either a sub-0.2 wt% binder loading or fully binder-free cold/warm pressing under controlled atmosphere, eliminating the hydration pathway entirely. The resulting film format is intended to be compatible with dry-room electrode stack manufacturing — the same industrial infrastructure that lithium-ion pouch cell and solid-state lithium manufacturers are now building out, and which sodium solid-state cell makers will inherit. An optional sodium-metal interfacial stabilization layer (referenced as an Na4P2S6 / Na2P2S6 interfacial limb) addresses the well-known reactivity between sulfide electrolytes and sodium metal anodes, forming a controlled interphase rather than an uncontrolled one. The remaining validation gate is AC-impedance spectroscopy on genuinely anhydrous dry-film specimens. Until that measurement is in hand, the ionic conductivity of the dry-film form factor is inferred from the literature on hydrate-derived Na3SbS4 (where room-temperature conductivities around 1 mS/cm have been reported) rather than measured directly on material produced by the claimed process. This is a meaningful gap: the entire commercial claim rests on process differentiation, and demonstrating that the dry-film anhydrous route achieves competitive conductivity — ideally at or above the hydrate-derived baseline — is the single most important near-term experimental priority. Without that data, the asset is a well-structured process claim with a credible scientific rationale but incomplete empirical support.

The addressable market for this asset is best framed as the subset of the broader sodium solid-state battery electrolyte market where thioantimonate chemistries are commercially viable and where dry-film manufacturing processes are in active use. Sodium solid-state batteries are being developed primarily for stationary storage and low-cost EV applications, driven by the relative abundance of sodium versus lithium. The total addressable market for sodium solid-state electrolyte materials and processes is estimated at $0.5 to $2 billion, reflecting the early stage of the industry and the significant uncertainty in adoption timing. These are estimates, not projections, and the range is wide because sodium solid-state cell commercialization is genuinely in its early phase. The direct customers for a license under this asset are sodium cell manufacturers — particularly those building out sulfide solid-state electrolyte lines — and electrolyte material suppliers who face composition-level blocking patents and need an alternative synthesis route. The asset's value proposition is explicitly as a backstop: it is not positioned as the primary commercial choice but as the route a manufacturer can fall back on if the preferred divalent-doped Na3PS4 path is blocked in a given jurisdiction. This means the licensing logic is partially tied to freedom-to-operate opinions and legal risk management as much as to materials performance, which is unusual but not unprecedented in specialty chemistry portfolios. Royalty logic for process-level claims in electrolyte manufacturing typically runs 1 to 3 percent of electrolyte material sales or a per-cell capacity fee, reflecting the narrower scope of process versus composition protection. The ceiling here is lower than for a broad composition claim but the floor is also more defensible, because a dry-film process claim survives even as composition prior art accumulates. For a GWh-scale sodium cell manufacturer running at meaningful electrolyte film throughput, even a 1 percent royalty on a $20-to-$50 per kWh electrolyte cost basis generates commercially meaningful license revenue. The market opportunity is therefore real but contingent — it materializes most clearly in scenarios where the thiophosphate-first strategy faces unexpected patent friction.

FTO backstop if divalent-doped Na3PS4 composition is unavailable in a jurisdiction

anhydrous hydrate-free dry-film + interfacial architecture; optional Se outside published genera

The natural home for this asset is a sodium solid-state cell manufacturer or a specialty electrolyte material supplier who is building out sulfide solid-state lines and has received a freedom-to-operate opinion indicating risk around divalent-doped Na3PS4 in one or more jurisdictions. Battery manufacturers in China and South Korea who are advancing sodium-ion programs — including CATL's sodium line, HiNa, and their electrolyte suppliers — represent the clearest near-term licensing prospects, because they operate across jurisdictions where incumbent thioantimonate composition claims may carry varying enforceability. The asset is also attractive to any party acquiring the broader dry-film sodium thiophosphate process family, for whom this thioantimonate route provides portfolio depth and FTO resilience at modest incremental cost. Secondary buyers include materials companies (sulfide electrolyte toll manufacturers, specialty chemical suppliers) who want to offer a dry-film processing service to cell makers without navigating composition-level licensing negotiations with thioantimonate incumbents. For those parties, a licensed dry-film process claim provides a commercial umbrella that the composition prior art does not preclude. The asset is unlikely to attract standalone acquisition interest at significant valuation; its value is highest when bundled with the broader family, where it functions as the documented alternative route that makes the family's overall process claims more resilient to challenge.

The primary risk is that the dry-film form factor, when actually fabricated and tested, does not achieve ionic conductivity competitive with hydrate-derived Na3SbS4 or with the preferred Na3PS4-based electrolytes in the broader portfolio. If the anhydrous dry-film process introduces grain boundary resistance or processing defects that degrade conductivity below approximately 0.1 mS/cm, the asset loses its technical rationale — there is no commercial incentive to take a license on a process that produces inferior material. This risk is de-risked by executing the AC-impedance measurement program on anhydrous dry-film specimens, which is identified as the single open validation gate. The scientific basis for expecting competitive conductivity is sound (the superionic literature supports it), but the measurement must be made. The secondary risk is patent scope erosion: if prior art is identified that specifically covers anhydrous dry-film processing of sodium thioantimonate — as opposed to thiophosphate or LGPS — the narrow FTO carve-out narrows further, potentially to the specific interfacial architecture alone. The roadmap to manage this risk is a supplementary prior art search focused on anhydrous sodium thioantimonate processing, combined with claim narrowing or continuation practice to anchor the protected scope to the most defensible combination of process conditions and interfacial architecture. The asset is a backstop by design, and its risk profile should be evaluated relative to that role rather than against a primary composition claim — the appropriate question is not "is this as strong as a composition patent?" but "does it provide meaningful FTO resilience for the family at acceptable cost to maintain?"